Date published: 
4 February 2021
Intended audience: 
General public
Covid-19 Vaccination

Australia has secured an extra 10 million doses of the Pzifer/BioNTech COVID-19 vaccine, bringing the total number of doses of this vaccine to 20 million.

The vaccine was provisionally approved for use in Australia by the Therapeutic Goods Administration (TGA) in January.

The additional doses will be available in the second half of 2021.

The vaccine rollout remains on track to begin in late February, with vaccines rolled out at thousands of sites across the nation throughout the year.

The Pfizer/BioNTech agreement is one of four separate agreements for the supply of COVID-19 vaccines in Australia.